[
  {
    "ts": null,
    "headline": "PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?",
    "summary": "Prothena slashes 63% of its workforce and axes birtamimab after trial failure, reshaping its pipeline and financial outlook. Shares plunge 53.5% YTD.",
    "url": "https://finnhub.io/api/news?id=de03a552fba3e1a62bea1cf565212c8a29c62d4358317bfba6416c5403ac42d0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751651460,
      "headline": "PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects?",
      "id": 135754768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Prothena slashes 63% of its workforce and axes birtamimab after trial failure, reshaping its pipeline and financial outlook. Shares plunge 53.5% YTD.",
      "url": "https://finnhub.io/api/news?id=de03a552fba3e1a62bea1cf565212c8a29c62d4358317bfba6416c5403ac42d0"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says “Bristol Myers has a Faint Pulse”",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the 25 stocks Jim Cramer recently shared insights on. While discussing drug stocks, Cramer mentioned BMY and said: “Of course, some of the rally’s nothing more than the left-behind stocks playing catch up. The drug stocks had a rare day in the sun. I wish I had something […]",
    "url": "https://finnhub.io/api/news?id=707490c16595c1efe870438c8263543bafa7c68f42c26566b5f64e3d68f11f12",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751612679,
      "headline": "Jim Cramer Says “Bristol Myers has a Faint Pulse”",
      "id": 135753534,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the 25 stocks Jim Cramer recently shared insights on. While discussing drug stocks, Cramer mentioned BMY and said: “Of course, some of the rally’s nothing more than the left-behind stocks playing catch up. The drug stocks had a rare day in the sun. I wish I had something […]",
      "url": "https://finnhub.io/api/news?id=707490c16595c1efe870438c8263543bafa7c68f42c26566b5f64e3d68f11f12"
    }
  }
]